Xbrane Biopharma AB 2022 Integrated Report
Company: Xbrane Biopharma AB
Sector: Manufacturing
Country: Sweden
Year: 2022
Type: Integrated Report
Pages: 92
The report describes Xbrane's 2022 sustainability work, including EU marketing authorization for Ximluci® and 15 patent applications supporting access to cost-effective medicines. It reports implementation of ESG reporting, 100% employee training in the Code of Conduct, and measurement of greenhouse gas emissions, with no Scope 1 emissions and 10 tonnes of Scope 2 emissions. The company also highlights continued workforce growth, Great Place to Work certification, and a 61% women and 39% men employee distribution.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.